Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phospholipase A2 group XV (PLA2G15) is a lysosomal enzyme with both phospholipase and transacylase activities, uniquely localized within the lysosome and late endosome[1][2][5]. It regulates intracellular lipid homeostasis and processes both oxidized and non-oxidized phospholipids, hydrolyzing the fatty acid at the sn-1 or sn-2 position as well as functioning as a transacylase[1][2]. Its activity can occur at acidic lysosomal pH, and it may also act at neutral pH when secreted or present in plasma[1]. PLA2G15 is involved in lipid catabolism, immune cell function, and potentially the metabolism of surfactant and oxidized lipids, but its direct disease associations and roles as a therapeutic target remain under investigation[1][2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phospholipase A2 group XV (PLA2G15).